{"disease":{"id":"erb-b2-receptor-tyrosine-kinase-exon-20-mutation","name":"erb b2 receptor tyrosine kinase exon 20 mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05800340","title":"Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}